Migraine
📧 Sign up to get email alerts when something new happens for Migraine.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-08-13Clinical Trial Update: Candesartan for Migraine Prevention: [Phase 2]
A Phase 2 clinical trial evaluating candesartan for migraine prevention has completed. The study was sponsored by St. Olavs Hospital.
-
CLINICAL_TRIALS trial_result · 2025-08-13Clinical Trial Update: A Study to Learn About Zavegepant as the Acute Treatment of Migraine in Asian Adults [Phase 3]
Pfizer conducted a Phase 3 trial evaluating zavegepant for the acute treatment of migraine in Asian adults. The study has completed, accordi…
-
CLINICAL_TRIALS trial_result · 2025-08-13Clinical Trial Update: Evaluation of the Prophylactic Efficacy of tDCS in Chronic Migraine [NA]
A completed clinical trial evaluated the prophylactic efficacy of transcranial direct current stimulation (tDCS) for chronic migraine.
-
CLINICAL_TRIALS research · 2025-08-13Clinical Trial Update: Endometriosis and Migraine
A clinical trial sponsored by Washington University School of Medicine is recruiting to study endometriosis and migraine.
-
CLINICAL_TRIALS research · 2025-08-13Clinical Trial Update: Migraine in Adolescents [NA]
This ClinicalTrials.gov update indicates a recruiting trial in adolescents focused on migraine, sponsored by Washington University School of…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-08-12FDA Approved: DIVALPROEX SODIUM — Original Application (First Nation Group, LLC)
FDA approved the original ANDA for divalproex sodium from First Nation Group, LLC, authorizing a generic product to be marketed for the same…
-
CLINICAL_TRIALS research · 2025-08-12Clinical Trial Update: nVNS for the Prevention and Treatment of Primary Headache [NA]
Clinical trial evaluating non-invasive vagus nerve stimulation for prevention and treatment of primary headache disorders, including migrain…
-
CLINICAL_TRIALS trial_result · 2025-08-11Clinical Trial Update: A Study to Learn About the Benefit of Rimegepant Versus Triptans in Migraine Buddy App Users.
Pfizer-led trial comparing rimegepant with triptans in people with migraine using the Migraine Buddy app has completed and results are poste…
-
CLINICAL_TRIALS research · 2025-08-11Clinical Trial Update: Long-term Extension Study to Assess Adverse Events of Oral Atogepant Tablets in Pediatric Participants (6 to 17 Years of Age) With Migraine [Phase 3]
A long-term extension study to assess adverse events of oral atogepant tablets in pediatric participants (6 to 17 years old) with migraine, …
-
FDA approval · 2025-08-05FDA Approved: AJOVY — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for AJOVY (fremanezumab-vfrm) from Teva, updating its labeling to reflect the approved supplemental …
-
CLINICAL_TRIALS trial_result · 2025-08-05Clinical Trial Update: Botulinum Toxin Type A Blockade of the Sphenopalatine Ganglion in Treatment-refractory Chronic Migraine [Phase 3]
A Phase 3 clinical trial is investigating botulinum toxin type A blockade of the sphenopalatine ganglion for treatment-refractory chronic mi…
-
CLINICAL_TRIALS trial_result · 2025-08-05Clinical Trial Update: Comorbidity-Based Propranolol Use in Pediatric Migraine
A completed clinical study evaluates comorbidity-based propranolol use in pediatric migraine patients. The update indicates the trial (NCT07…
-
CLINICAL_TRIALS research · 2025-08-05Clinical Trial Update: i-NEED: NEw migrainE Drugs Database
The update indicates that the i-NEED study, a database of new migraine drugs, is currently recruiting at IRCCS San Raffaele Roma for episodi…
-
FDA approval · 2025-08-01FDA Approved: NURTEC ODT — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved Pfizer's supplemental application for Nurtec ODT (rimegepant sulfate). The approval updates/expands the product's labeling …
-
FDA approval · 2025-08-01FDA Approved: ZAVZPRET — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approves a supplemental application for Zavzpret (zavegepant) submitted by Pfizer Laboratories Div Pfizer Inc.
-
CLINICAL_TRIALS trial_result · 2025-07-31Clinical Trial Update: Nerivio Efficacy by Time of Treatment Onset [Phase 4]
Phase 4 study evaluating Nerivio's efficacy in migraine treatment as a function of time of treatment onset. The trial status is completed.
-
CLINICAL_TRIALS other · 2025-07-31Clinical Trial Update: A Study With Intranasal Kinetic Oscillation Stimulation (KOS) in the Prevention of Chronic Migraine [NA]
A clinical trial evaluating intranasal kinetic oscillation stimulation (KOS) for prevention of chronic migraine has been terminated. No resu…
-
CLINICAL_TRIALS research · 2025-07-30Clinical Trial Update: Evaluation of Efficacy and Safety of Topical Cannabidiol (Canvert-M Produced by Alasht Pharmed co. Iran) in the Treatment of Migraine Attacks [Phase 4]
A Phase 4 clinical trial is evaluating the efficacy and safety of a topical cannabidiol product (Canvert-M) for migraine attacks. Recruitmen…
-
CLINICAL_TRIALS research · 2025-07-29Clinical Trial Update: The Efficacy of Beneficial Intestinal Microbiota in the Treatment of Migraine and Its Mechanism: Basic and Clinical Studies [NA]
This clinical trial registry entry outlines a study on the efficacy and mechanism of using beneficial gut microbiota to treat migraine, incl…
-
CLINICAL_TRIALS withdrawal · 2025-07-29Clinical Trial Update: Haldol/Diphenhydramine Versus Metoclopramide/Diphenhydramine for Treatment of Acute Headache in the ED: A RCT [Phase 4]
A Phase 4 randomized trial comparing haloperidol with diphenhydramine versus metoclopramide with diphenhydramine for acute headaches (migrai…
-
CLINICAL_TRIALS research · 2025-07-28Clinical Trial Update: Potential Osteocatabolic Effect Caused by Anti-CGRP mAbs in Migraine Patients Treated With Anti-CGRP mAbs - an Observational Pilot Project With Prospectively Collected Health Related Data
An observational pilot study to explore potential bone metabolism (osteocatabolic) effects in migraine patients treated with anti-CGRP monoc…
-
CLINICAL_TRIALS research · 2025-07-28Clinical Trial Update: Occipital Nerve Stimulation in Chronic Migraine [NA]
University College London is conducting a trial of occipital nerve stimulation for chronic migraine. The study is currently not recruiting.
-
FDA approval · 2025-07-25FDA Approved: SUMATRIPTAN — Supplemental Application (Eugia US LLC)
FDA approved a supplemental application for Sumatriptan from Eugia US LLC under ANDA 202758.
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: China Headache and Vertigo Registry Study
Clinical trial registry entry for the China Headache and Vertigo Registry Study from Zhejiang University; the study is currently recruiting …
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: Individualized Location-based rTMS for Migraine Treatment: A Multicenter Clinical Study [NA]
A multicenter clinical study evaluating individualized location-based repetitive transcranial magnetic stimulation (rTMS) for migraine treat…